Roche Holding AG banner

Intrinsic Value

Is RHHBF undervalued or overvalued?

See the intrinsic value estimate for Roche Holding AG and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

RHHBF Intrinsic Value
LOCKED
Unlock
Today vs. history

RHHBF looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with RHHBF’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor RHHBF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price $442.28
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to RHHBF

Fundamental Analysis

What Roche Does

Pharmaceuticals Health Care

Roche Holding AG is a Swiss healthcare company that makes prescription medicines and diagnostic tests. Its drug business focuses on treatments in cancer, immunology, ophthalmology, and other serious diseases, while its diagnostics business sells instruments, lab tests, and software that help hospitals and laboratories detect disease and monitor patients. In simple terms, Roche helps doctors find illnesses and choose treatments, and it earns money by selling these medicines, test kits, and related systems to healthcare providers and distributors.

Headquarters
Switzerland CH
Employees
100 920
IPO date
May 4, 2001
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Roche Holding AG

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one RHHBF stock?

The intrinsic value for Roche Holding AG (RHHBF) under the Base Case is hidden USD.

Is RHHBF stock undervalued or overvalued?

Compared with the current market price of 442.275 USD, the stock appears hidden.

Back to Top